Parkman Healthcare Partners LLC: 13F holdings
CIK 17770152026Q2
| Positions | 77 |
|---|---|
| Reported value | $976.8m |
| Filed | 2026-08-14 |
Top 10 holdings
| Security | Shares | Value | Weight |
|---|---|---|---|
| MBX BIOSCIENCES INC | 800,173 | $44.2m | 4.5% |
| LLY ELI LILLY & CO | 35,000 | $42.0m | 4.3% |
| CVS CVS HEALTH CORP | 391,791 | $40.5m | 4.1% |
| DXCM DEXCOM INC | 534,767 | $36.0m | 3.7% |
| PTCT PTC THERAPEUTICS INC | 435,691 | $35.5m | 3.6% |
| RCUS ARCUS BIOSCIENCES INC | 919,266 | $28.3m | 2.9% |
| STRUCTURE THERAPEUTICS INC | 485,661 | $26.1m | 2.7% |
| VIRIDIAN THERAPEUTICS INC | 1,377,576 | $25.3m | 2.6% |
| AGIO AGIOS PHARMACEUTICALS INC | 669,046 | $24.8m | 2.5% |
| INHIBRX BIOSCIENCES INC | 256,950 | $24.3m | 2.5% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1777015")Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.